Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Russo

Showing results (11-20 of 419) with videos related to

Pageof 42
Sort By:
Cancer Discovery|May 3, 2020
<i>HER2</i> Mutations in Non-Small Cell Lung Cancer: A Herculean Effort to Hit the TargetChristian Rolfo, Alessandro Russo
Microorganisms|April 26, 2025
The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>Alessandro Russo, Francesca Serapide
Internal and Emergency Medicine|October 19, 2023
Considerations about antibiotic management for community-acquired pneumonia: unmet needs and future perspectivesSara Palma Gullì, Alessandro Russo
Hospital Practice (1995)|September 1, 2018
Management of patients with septic shock due to Candida infectionMatteo Bassetti, Antonio Vena, Alessandro Russo
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 28, 2015
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literatureMarco Falcone, Alessandro Russo, Mario Venditti
Internal and Emergency Medicine|November 30, 2013
Early identification of severe community-onset pneumonia in "frail elderly patient"Alessandro Russo, Marco Falcone, Mario Venditti
JCO Precision Oncology|February 27, 2023
Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel <i>MET</i> Exon 14 Variants in Non-Small-Cell Lung CancerChristian Rolfo, Umberto Malapelle, Alessandro Russo
Med (New York, N.Y.)|February 10, 2024
LIBRETTO-431: Is it time to reconsider randomized phase 3 trials for uncommon oncogenic drivers in non-small-cell lung cancer?Alessandro Russo, Paola Muscolino, Christian Rolfo
Current Opinion in Infectious Diseases|March 4, 2022
Antibiotic treatment of acute bacterial skin and skin structure infectionsAlessandro Russo, Antonio Vena, Matteo Bassetti
Ebiomedicine|May 8, 2023
The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?Christian Rolfo, Alessandro Russo, Umberto Malapelle
Pageof 42

Showing results (11-20 of 419) with videos related to

Sort By:
Pageof 42
Cancer Discovery|May 3, 2020
<i>HER2</i> Mutations in Non-Small Cell Lung Cancer: A Herculean Effort to Hit the TargetChristian Rolfo, Alessandro Russo
Microorganisms|April 26, 2025
The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>Alessandro Russo, Francesca Serapide
Internal and Emergency Medicine|October 19, 2023
Considerations about antibiotic management for community-acquired pneumonia: unmet needs and future perspectivesSara Palma Gullì, Alessandro Russo
Hospital Practice (1995)|September 1, 2018
Management of patients with septic shock due to Candida infectionMatteo Bassetti, Antonio Vena, Alessandro Russo
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 28, 2015
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literatureMarco Falcone, Alessandro Russo, Mario Venditti
Internal and Emergency Medicine|November 30, 2013
Early identification of severe community-onset pneumonia in "frail elderly patient"Alessandro Russo, Marco Falcone, Mario Venditti
JCO Precision Oncology|February 27, 2023
Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel <i>MET</i> Exon 14 Variants in Non-Small-Cell Lung CancerChristian Rolfo, Umberto Malapelle, Alessandro Russo
Med (New York, N.Y.)|February 10, 2024
LIBRETTO-431: Is it time to reconsider randomized phase 3 trials for uncommon oncogenic drivers in non-small-cell lung cancer?Alessandro Russo, Paola Muscolino, Christian Rolfo
Current Opinion in Infectious Diseases|March 4, 2022
Antibiotic treatment of acute bacterial skin and skin structure infectionsAlessandro Russo, Antonio Vena, Matteo Bassetti
Ebiomedicine|May 8, 2023
The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?Christian Rolfo, Alessandro Russo, Umberto Malapelle
Pageof 42